These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15450852)

  • 1. A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma.
    Hwang IK; Park SM; Kim SY; Lee ST
    Biochim Biophys Acta; 2004 Oct; 1702(1):79-87. PubMed ID: 15450852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of plasma gelsolin as a substrate for matrix metalloproteinases.
    Park SM; Hwang IK; Kim SY; Lee SJ; Park KS; Lee ST
    Proteomics; 2006 Feb; 6(4):1192-9. PubMed ID: 16421935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C-II is a novel substrate for matrix metalloproteinases.
    Kim SY; Park SM; Lee ST
    Biochem Biophys Res Commun; 2006 Jan; 339(1):47-54. PubMed ID: 16314153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
    Hurst DR; Schwartz MA; Ghaffari MA; Jin Y; Tschesche H; Fields GB; Sang QX
    Biochem J; 2004 Feb; 377(Pt 3):775-9. PubMed ID: 14533979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
    Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
    Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display.
    Pan W; Arnone M; Kendall M; Grafstrom RH; Seitz SP; Wasserman ZR; Albright CF
    J Biol Chem; 2003 Jul; 278(30):27820-7. PubMed ID: 12738779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
    Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K
    J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
    Kolkenbrock H; Essers L; Ulbrich N; Will H
    Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the catalytic domain of human matrix metalloproteinase 10.
    Bertini I; Calderone V; Fragai M; Luchinat C; Mangani S; Terni B
    J Mol Biol; 2004 Feb; 336(3):707-16. PubMed ID: 15095982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of substrate specificity of rat neurolysin from matrix metalloproteinase-2/9-type to -3-type specificity by comprehensive mutation.
    Kadonosono T; Kato-Murai M; Ueda M
    Protein Eng Des Sel; 2008 Aug; 21(8):507-13. PubMed ID: 18499680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
    Minond D; Lauer-Fields JL; Nagase H; Fields GB
    Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane type-matrix metalloproteinases and tumor progression.
    Sounni NE; Noel A
    Biochimie; 2005; 87(3-4):329-42. PubMed ID: 15781320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.
    Puente XS; Pendás AM; Llano E; Velasco G; López-Otín C
    Cancer Res; 1996 Mar; 56(5):944-9. PubMed ID: 8640782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome.
    Dean RA; Overall CM
    Mol Cell Proteomics; 2007 Apr; 6(4):611-23. PubMed ID: 17200105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H; Werle K; Bauer MM; Dollinger H; Jung B
    J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors.
    Llano E; Pendás AM; Freije JP; Nakano A; Knäuper V; Murphy G; López-Otin C
    Cancer Res; 1999 Jun; 59(11):2570-6. PubMed ID: 10363975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of apolipoprotein A-I as a substrate for matrix metalloproteinase-14.
    Park JH; Park SM; Park KH; Cho KH; Lee ST
    Biochem Biophys Res Commun; 2011 May; 409(1):58-63. PubMed ID: 21549099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta.
    Wei P; Zhao YG; Zhuang L; Ruben S; Sang QX
    Biochem Biophys Res Commun; 2001 Jan; 280(3):744-55. PubMed ID: 11162584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates.
    Cauwe B; Martens E; Proost P; Opdenakker G
    Integr Biol (Camb); 2009 Jun; 1(5-6):404-26. PubMed ID: 20023747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.